11. Higher‐order interactions of Bcr‐Abl can broaden chronic myeloid leukemia (CML) drug repertoire. (28th December 2022) Authors: Liu, Yonglan; Zhang, Mingzhen; Jang, Hyunbum; Nussinov, Ruth Journal: Protein science Issue: Volume 32:Number 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Independent and core pathways in oncogenic KRAS signaling. (2nd August 2016) Authors: Nussinov, Ruth; Tsai, Chung-Jung; Jang, Hyunbum Journal: Expert review of proteomics Issue: Volume 13:Number 8(2016) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Inhibition of Nonfunctional Ras. Issue 2 (18th February 2021) Authors: Nussinov, Ruth; Jang, Hyunbum; Gursoy, Attila; Keskin, Ozlem; Gaponenko, Vadim Journal: Cell chemical biology Issue: Volume 28:Issue 2(2021) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Inhibitors of Ras–SOS Interactions. (2nd December 2015) Authors: Lu, Shaoyong; Jang, Hyunbum; Zhang, Jian; Nussinov, Ruth Journal: ChemMedChem Issue: Volume 11:Number 8(2016) Page Start: 814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?. (February 2019) Authors: Nussinov, Ruth; Tsai, Chung-Jung; Jang, Hyunbum Journal: Seminars in cancer biology Issue: Volume 54(2019) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?. (2nd July 2016) Authors: Nussinov, Ruth; Muratcioglu, Serena; Tsai, Chung-Jung; Jang, Hyunbum; Gursoy, Attila; Keskin, Ozlem Journal: Expert opinion on therapeutic targets Issue: Volume 20:Number 7(2016:Jul.) Page Start: 831 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Mechanism of activation and the rewired network: New drug design concepts. Issue 2 (25th October 2021) Authors: Nussinov, Ruth; Zhang, Mingzhen; Maloney, Ryan; Tsai, Chung‐Jung; Yavuz, Bengi Ruken; Tuncbag, Nurcan; Jang, Hyunbum Journal: Medicinal research reviews Issue: Volume 42:Issue 2(2022) Page Start: 770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Oligomerization and nanocluster organization render specificity. (11th June 2014) Authors: Nussinov, Ruth; Jang, Hyunbum; Tsai, Chung‐Jung Journal: Biological reviews Issue: Volume 90:Number 2(2015:May) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling. Issue 4 (14th February 2020) Authors: Muratcioglu, Serena; Aydin, Cihan; Odabasi, Ezgi; Ozdemir, E. Sila; Firat-Karalar, Elif Nur; Jang, Hyunbum; Tsai, Chung-Jung; Nussinov, Ruth; Kavakli, Ibrahim Halil; Gursoy, Attila; Keskin, Ozlem Journal: Journal of molecular biology Issue: Volume 432:Issue 4(2020) Page Start: 1199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Oncogenic KRas mobility in the membrane and signaling response. (February 2019) Authors: Nussinov, Ruth; Tsai, Chung-Jung; Jang, Hyunbum Journal: Seminars in cancer biology Issue: Volume 54(2019) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗